Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Positively Charged Eye Treatment Emulsion Technology Wins Kaye Award For Hebrew University Researcher

08.06.2005


A method using positively charged emulsions for improving drug delivery to treat eye diseases has won for Prof. Shimon Benita of the Hebrew University of Jerusalem School of Pharmacy a Kaye Innovation Award.



The award was presented on June 6 during the 68TH Hebrew University Board of Governors meeting.

Novagali Pharma, a drug delivery and biotechnology startup company based in a Paris suburb, and Prof. Benita’s research group have shown that their technology, based on positively charged emulsions, have a definite advantage over existing medications, including those emulsions that have no charge or with a negative charge.


The surface of the eye bears a negative charge; therefore, when the positively-charged emulsions -- containing an oily core in which the desired active drug compound is dissolved -- reach the eye surface, the medication is more speedily and effectively absorbed than in existing preparations. This promises great potential for Novagali in the development of future eye medications.

Founded in 2000 by Prof. Benita and the Hebrew University’s Yissum Research Development Company, Novagali has succeeded since its founding in raising nearly 18 million euros from French venture capital firms.

Cationorm, one of the new products developed by Novagali, has completed phase 2 clinical trials for treatment of low and moderate degree dry eye syndrome, with another set of trials now having just begun in France for treatment of the more severe form.

Also under investigation is the use of this method of drug delivery for treatment of severe diseases of the posterior portions of the eye, especially the retina. The ability to deliver medications to this portion of the eye without injections could provide a significant breakthrough for Novagali.

The Kaye Innovation Awards have been presented annually since 1994. They were established by Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, in order to encourage faculty and staff of the university to develop innovative methods and inventions with good commercial potential which will benefit the university and society.

Jerry Barach | alfa
Further information:
http://www.huji.ac.il

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Bodyguards in the gut have a chemical weapon

20.01.2017 | Life Sciences

SF State astronomer searches for signs of life on Wolf 1061 exoplanet

20.01.2017 | Physics and Astronomy

Treated carbon pulls radioactive elements from water

20.01.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>